For: | Wu YF, Yu WJ, Jiang YH, Chen Y, Zhang B, Zhen RB, Zhang JT, Wang YP, Li Q, Xu F, Shi YJ, Li XP. COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report. World J Clin Cases 2021; 9(19): 5266-5269 [PMID: 34307577 DOI: 10.12998/wjcc.v9.i19.5266] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i19/5266.htm |
Number | Citing Articles |
1 |
Roberto Ponce-Pincay, Callejas Diana. Reactivación y coinfecciones virales en COVID-19: otro elemento a considerar. Revisión Sistemática. Kasmera 2023; 51 doi: 10.56903/kasmera.5138571
|
2 |
Mehakmeet Bhatia, Pranatharthi Chandrasekar. Hepatitis B Reactivation Following COVID-19. Annals of Internal Medicine: Clinical Cases 2024; 3(11) doi: 10.7326/aimcc.2024.0253
|
3 |
Sara Redenšek Trampuž, David Vogrinc, Katja Goričar, Vita Dolžan. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. Frontiers in Molecular Neuroscience 2023; 16 doi: 10.3389/fnmol.2023.1123955
|
4 |
Entecavir/interferon-α-2b/methylprednisolone. Reactions Weekly 2021; 1867(1): 173 doi: 10.1007/s40278-021-00233-7
|
5 |
Yan-Fei He, Zhi-Gang Jiang, Ni Wu, Ning Bian, Jun-Lin Ren. Correlation between COVID-19 and hepatitis B: A systematic review. World Journal of Gastroenterology 2022; 28(46): 6599-6618 doi: 10.3748/wjg.v28.i46.6599
|
6 |
Farina M Hanif, Zain Majid, Shoaib Ahmed, Nasir H Luck, Muhammed Mubarak. Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective. World Journal of Virology 2022; 11(6): 453-466 doi: 10.5501/wjv.v11.i6.453
|
7 |
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection. Journal of Clinical Virology Plus 2023; 3(4): 100167 doi: 10.1016/j.jcvp.2023.100167
|
8 |
Ioannis Braimakis, Sofia Vasileiadi, Eleni-Myrto Trifylli, Nikolaos Papadopoulos, Melanie Deutsch. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?. Livers 2023; 3(3): 347 doi: 10.3390/livers3030026
|
9 |
Muhammad Mushtaq, Keegan Colletier, Akshata Moghe. Hepatitis B Reactivation and Liver Failure Because of COVID-19 Infection. ACG Case Reports Journal 2024; 11(7): e01397 doi: 10.14309/crj.0000000000001397
|
10 |
Nicoleta Mihai, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, Victoria Aramă. Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study. Journal of Clinical Medicine 2024; 13(20): 6032 doi: 10.3390/jcm13206032
|
11 |
Pan Yan, Xiaoping Yu, Zhu Chen, Lijuan Lan, Jun Kang, Bennan Zhao, Dafeng Liu. Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03770-w
|
12 |
Caterina Sagnelli, Antonello Sica, Massimiliano Creta, Alessandra Borsetti, Massimo Ciccozzi, Evangelista Sagnelli. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens 2022; 11(5): 567 doi: 10.3390/pathogens11050567
|
13 |
Jenny Yeon Hee Kim, Martin Ragusa, Fernando Tortosa, Ana Torres, Lionel Gresh, Jairo Andres Méndez-Rico, Carlos Arturo Alvarez-Moreno, Thiago Costa Lisboa, Sandra Liliana Valderrama-Beltrán, Sylvain Aldighieri, Ludovic Reveiz. Viral reactivations and co-infections in COVID-19 patients: a systematic review. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08117-y
|
14 |
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, Mariantonietta Pisaturo, Loredana Alessio, Stefania De Pascalis, Evangelista Sagnelli, Nicola Coppola. COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature. Pathogens 2022; 11(7): 816 doi: 10.3390/pathogens11070816
|